CD1a selectively captures endogenous cellular lipids that broadly block T cell response

Rachel N. Cotton, Marcin Wegrecki, Tan-Yun Cheng, Yi-Ling Chen, Natacha Veerapen, Jérôme Le Nours, Dennis P. Orgill, Bohdan Pomahac, Simon G. Talbot, Richard Willis, John D. Altman, Annemieke de Jong, Ildiko van Rhijn, Rachael A. Clark, Gurdyal S. Besra, Graham Ogg, Jamie Rossjohn, D. Branch Moody

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

We optimized lipidomics methods to broadly detect endogenous lipids bound to cellular CD1a proteins. Whereas membrane phospholipids dominate in cells, CD1a preferentially captured sphingolipids, especially a C42, doubly unsaturated sphingomyelin (42:2 SM). The natural 42:2 SM but not the more common 34:1 SM blocked CD1a tetramer binding to T cells in all human subjects tested. Thus, cellular CD1a selectively captures a particular endogenous lipid that broadly blocks its binding to TCRs. Crystal structures show that the short cellular SMs stabilized a triad of surface residues to remain flush with CD1a, but the longer lipids forced the phosphocholine group to ride above the display platform to hinder TCR approach. Whereas nearly all models emphasize antigen-mediated T cell activation, we propose that the CD1a system has intrinsic autoreactivity and is negatively regulated by natural endogenous inhibitors selectively bound in its cleft. Further, the detailed chemical structures of natural blockers could guide future design of therapeutic blockers of CD1a response.

Original languageEnglish
Article numbere20202699
Number of pages20
JournalJournal of Experimental Medicine
Volume218
Issue number7
DOIs
Publication statusPublished - 5 Jul 2021

Cite this